News About: Pharm. Industry


Dong-A Pharm launches liquid-type human growth hormone grotropin-II injection

Dong-A Pharm announced it has launched a liquid-type human growth hormone grotropin-II injection based on the EP standards for the first time in Korea after successful developme...

Yungjin Pharm to mull pain-in capital increase of 20 billion won

Yungjin Pharm unveiled a plan to lure domestic investors via its pain-in capital increase of 20 billion won by designating the third party on March 2004. To that end, the company will hold its special shareholders...

Pharmaceutical industry skeptical of large corporations' advancement into pharmacy market

Although some large companies have recently renewed their keen interest in entering domestic pharmacy market, the existing pharmacy chain firms including drug makers are skeptical of their success albeit growing conce...

Green Cross to start vaccine plant construction in Vietnam.

Green Cross Vaccine Inc. (President: Cornellis Monern) took a ground digging ceremony for the construction of a vaccine plant affiliated to the National Institute of Hygiene & Epidemiology(NIHE) of Vietnam in presenc...

Description for individual tablet identification to enforce from 2005.

For the prevention of any possible misuse of drugs, the KFDA is considering to adopt a provision of which an individual unit of oral solid formed drugs should be marked with an identification description taking effect...

Hanmi is set to establish its returned goods management center

Hanmi Pharm said on December 4 that it would set up a new grievance center to effectively deal with the excessive drug inventories at pharmacy upon request, including drugs whose shelf life was/will be expired. The...

CJ to introduce FSAD treatment Femprox

CJ announced it entered into an exclusive distribution agreement with the U.S.-based NexMed Inc. on November 21 for the introduction of Femprox, which is effective in treating female sexual arousal disorder (FSAD). ...

Lilly Korea is willingness to compensate wholesalers over pricing reduction portion of Zyprexa...

Lilly Korea is willingness to compensate wholesalers over pricing reduction portion of Zyprexa tablet Lilly Korea said on December 2 that it is willing to fully compensate the pricing reduction portion of domestic ...

Novartis Korea named Peter Maag as new president

Novartis Korea announced recently the appointment of Dr. Peter Maag as a new president and Dr. Frank Bobe, who was a former president for the Korean unit for three and half years, has become vice president of Novartis...

Company value to maximize with brand image.

"Brand is a competitiveness" becomes an axiom in the business arena these days, which seems to be quite true in the pharmaceutical companies. In the recent commercial advertising contest, quite a number of drug advert...

Most Read News


April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
SunMonTueWedThuFriSat
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.